References
- Thol F, Weissinger EM, Krauter J, . IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica 2010;95:1668–1674.
- Ward PS, Patel J, Wise DR, . The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010;17:225–234.
- Kosmider O, Gelsi-Boyer V, Slama L, . Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia 2010;24:1094–1096.
- Abdel-Wahab O, Pardanani A, Patel J, . Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms. Leukemia 2011;25:1200–1202.
- Yoshida K, Sanada M, Kato M, . A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders. Leukemia 2011;25:184–186.
- Jankowska AM, Makishima H, Tiu RV, . Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood 2011;118:3932–3941.
- Yamazaki J, Taby R, Vasanthakumar A, . Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics 2012;7:201–207.
- Zhao S, Lin Y, Xu W, . Glioma derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009;324:261–265.
- Dang L, White DW, Gross S, . Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009;462:739–744.
- Gross S, Cairns RA, Minden MD, . Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 2010;207:339–344.
- Green A, Beer P. Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med 2010;362:369–370.
- Wagner K, Damm F, Göhring G, . Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. J Clin Oncol 2010;28:2356–2364.
- Lin J, Yao DM, Qian J, . IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Ann Hematol 2012;91:519–525.
- Orazi A, Bennett JM, Germing U, . Chronic myelomonocytic leukaemia. In: Swerdlow S, Campos E, Harris NL, ., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp. 76–81.